Luisa F Escobar-Hoyos Selected Research

Keratin-17 (Keratin 17)

1/2022	Dissecting the Oncogenic Roles of Keratin 17 in the Hallmarks of Cancer.
11/2021	Keratin 17 testing in pancreatic cancer needle aspiration biopsies predicts survival.
10/2021	Keratin 17 Is a Novel Cytologic Biomarker for Urothelial Carcinoma Diagnosis.
1/2021	Keratin 17 Expression Predicts Poor Clinical Outcome in Patients With Advanced Esophageal Squamous Cell Carcinoma.
1/2020	An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer.
12/2019	Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas.
1/2019	Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer.
1/2019	Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia.
1/2018	Elevated expression of keratin 17 in oropharyngeal squamous cell carcinoma is associated with decreased survival.
9/2017	Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luisa F Escobar-Hoyos Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 09/2015
5	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 09/2015
3	Carcinoma (Carcinomatosis) 10/2021 - 09/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 04/2014
2	Squamous Intraepithelial Lesions 09/2017 - 04/2014
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Lymphatic Metastasis 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 12/2019
1	Endometrial Neoplasms (Endometrial Cancer) 12/2019
1	Adenocarcinoma 12/2019
1	Margins of Excision 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Lobular Carcinoma 01/2017
1	Ductal Carcinoma 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 07/2013

Drug/Important Bio-Agent (IBA)

13	Keratin-17 (Keratin 17)IBA 01/2022 - 04/2014
9	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2014
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2014
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2017
2	Biological ProductsIBA 01/2022 - 09/2015
2	Formaldehyde (Formol)FDA Link 01/2019 - 04/2014
2	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 09/2015
2	ParaffinIBA 01/2019 - 04/2014
2	Keratins (Keratin)IBA 01/2017 - 09/2015
1	CytosineIBA 10/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	human ERBB2 proteinIBA 01/2017
1	Estrogen ReceptorsIBA 01/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	Keratin-4 (Keratin 4)IBA 04/2014
1	SolventsIBA 07/2013

Therapy/Procedure

1	Precision Medicine 01/2022
1	Immunotherapy 03/2021
1	Therapeutics 03/2021
1	Drug Therapy (Chemotherapy) 03/2021